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Subject of this thesis is the development of an experimental model for
immune complex glomerulopathy, induced by inorganic mercury.
Inorganic mercury has been used in the past for the treatment of tuber-
culosis and syphilis. It has also been employed as a diuretic and in teething
powders. Mercury is still frequently used in antiseptic ointments and in
skin-l ightening creams.
Proteinuria and a nephrotic syndrome associated with membranous
glomerulopathy (MGP) in man have been recognized for a long time as
one of the complications of exposition to low doses of mercury. This form
of immune complex glomerulopathy, characterized by the presence of
immune aggregates along the epithelial side of the glomerular basement
membrane (GBM) can also be seen in patients treated with other drugs
(gold, penici l lamine, captopri l) .
The way the glomerulopathy is induced by mercury and the other drugs
is unclear, the more since the pathogenetic antigen is unknown. Experi-
mental studies of mercury-induced immune complex glomerulopathy
have not succeeded in identifying the pathogenetic antigen sofar. The idea,
that mercury would cause tubular cell damage, resulting in an anti-tubular
brushborder antibody response could not be confirmed by these experi-
mental studies.
The purpose of this study was to investigate pathogenetic mechanisms
in mercury-induced immune complex glomerulopathy in the PYG/c rat,
a high responder in the induction of autologous immune complex glo-
merulonephritis.
Chapter I describes the induction of the glomerulopathy. Administra-
tion of low doses of HgCI2, three times a week, results after about twelve
weeks in the development of IgG containing immune aggregates in a
granular pattern along the GBM and in the mesangium. Other immuno-
globulins and complement are not found in the aggregates. Proteinuria is
absent. Coinciding with the appearance of glomerular immune aggre-
gates, circulating antinuclear antibodies (ANA) are found in the sera of
the mercury injected rats. Acid eluates of the glomeruli contain ANA as
well, suggesting ANA to be present in the glomerular immune aggregates.
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Administration of a single dose of complete Freund's adjuvant at the
start of the mercury injections accelerates the development of ANA and
glomerular immune complex aggregates with approximately 4 weeks.
In chapter 2, the identification of the nuclear antigen is described, to
which mercury elicits an antibody response. This antigen is shown to be
a con A binding glycoprotein from the non-histon chromatin fraction.
In chapter 3, the mechanism of glomerular immune aggregate formation
is studied. Using ex zriuo perfusions and iz uitro incubations, antinuclear
antibodies belonging to the IgG serum fraction of mercury injected ani-
mals are shown to bind to normal rat GBM. Binding is not obtained,
when the antinuclear antibodies are absorbed with purified nuclei. These
results suggest, that antinuclear antibodies bind to or cross-react with
antigenic sites in the GBM.
Aspects of cellular immunity and immunoregulation in mercury diseased
rats are described in chapter 4. Lymphocytes from mercury injected rats
are found to be sensitized for nuclear and FxIA antigens, when studied in
a direct migration inhibition assay, but the lymphocytes show a decreased
mitogenic response to phytohaemagglutinin as compared with lympho-
cytes from control animals.
Con A-activated suppression, assessed in a co-culture system, is decreased
in lymphocytes from mercury diseased animals compared to the suppres-
sive activity, generated by con A in lymphocytes from control rats.
Mercury administration to PVG,/c rats after neonatal thymectomy is
found to result much earlier in the development of antinuclear antibodies
and glomerular immune aggregates than in non-thymectomized control
animals. This eÍÏect is not seen after adult thymectomy.
From these results it is concluded, that mercury-induced antibody
responses are associated with cell-mediated immune reactions and with a
disturbance of the immunoregulation. Whether or not these phenomena
are involved in the pathogenesis of the disease, remains to be elucidated.
In chapter 5, this issue and the results ofthe previous chapters are dis-
cussed. The differences with other models of mercury-induced immune
complex glomerulopathy are reviewed. So is the role of circulating
immune complexes as to the origin of vascular and mesangial immune
deposits. The binding of antinuclear antibodies to the GBM is compared
with corresponding findings in man and the similarity in binding capacity
between mercury-induced ANA, anti-FxlA antibodies and con A is dis-
cussed. The origin of the antinuclear antibody response is related to
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possible nuclear damage or to the changes in the immunoregulation, as
described in chapter 4.
The model offers an opportunity to investigate further the relation
between immunodysregulation, autoantibodies and the pathogenesis of
immune complex glomerulopathy, a relation which is thoroughly studied
in human pathology as well.
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